bioRxivMolecular BiologyPreprint
Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants
Larisa Troitskaya, Nelson L.S. Chan, Brendon T. Frank, Daniel J. Capon, Brian A. ZabeliD, Xiaomei Ge, Dan li LuoiD, Rachel Martinelli, Jing Jin, Graham SimmonsiD
Abstract
With the rapid spread of SARS-CoV-2 variants, including those that are resistant to antibodies authorized for emergency use, it is apparent that new antibodies may be needed to effectively protect patients against more severe disease. Differences between the murine and human antibody repertoires may allow for the isolation of murine monoclonal antibodies that recognize a different or broader range of SARS-CoV-2 variants than the human antibodies that have been characterized so far. We describe mouse antibodies B13 and O24 that demonstrate neutralizing potency against SARS-CoV-2 Wuhan (D614G) and B.1.351 variants. Such murine antibodies may have advantages in protecting against severe symptoms when individuals are exposed to new SARS-CoV-2 variants.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect in vivo in a mouse model in a neutralization dependent manner
F. Amanat, S. Strohmeier, … F. Krammer·bioRxiv·Apr 5, 2021
- Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)
M. Imbrechts, W. Kerstens, … N. Geukens·bioRxiv·Dec 21, 2021
- Novel monoclonal antibodies showing broad neutralizing activity for SARS-CoV-2 variants including Omicrons BA.5 and BA.2.75
H. Ishimaru, M. Nishimura, … Y. Mori·bioRxiv·Sep 2, 2022
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
M. Imbrechts, W. Maes, … N. Geukens·bioRxiv·Nov 25, 2021
- SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody
Mikhail Y. Lebedin, Nikolai Petrovsky, … Yuri S. Lebedin·Antiviral ResearchPeer-reviewed·Jul 15, 2025
- A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants
A. J. Schmitz, J. S. Turner, … A. H. Ellebedy·bioRxiv·Mar 24, 2021